Eton Pharmaceuticals, Inc.(ETON)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ETON Eton Pharmaceuticals, Inc.

已收盘 08-11 16:00:00 EDT

42.05

-1.62

-3.71%

盘后40.87

-1.18-2.81%

19:42 EDT

最高43.60	最低40.61	成交量58.46万
今开43.60	昨收43.67	日振幅6.85%
总市值11.47亿	流通市值8.85亿	总股本2,728万
成交额2,458万	换手率2.78%	流通股本2,105万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ETON","market":"US","secType":"STK","nameCN":"Eton Pharmaceuticals, Inc.","latestPrice":42.05,"timestamp":1786478400000,"preClose":43.67,"halted":0,"volume":584578,"hourTrading":{"tag":"盘后","latestPrice":40.87,"preClose":42.05,"latestTime":"19:42 EDT","volume":2746,"amount":115233.3,"timestamp":1786491764637,"change":-1.18,"changeRate":-0.028062,"amplitude":0.028062},"delay":0,"changeRate":-0.037096404854591356,"floatShares":21048500,"shares":27284491,"eps":-0.054613,"marketStatus":"已收盘","change":-1.62,"latestTime":"08-11 16:00:00 EDT","open":43.6,"high":43.6,"low":40.61,"amount":24580417.584919997,"amplitude":0.068468,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.054613,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786521600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1541739600000,"exchange":"NASDAQ","adjPreClose":43.67,"preHourTrading":{"tag":"盘前","latestPrice":43.1,"preClose":43.67,"latestTime":"09:25 EDT","volume":200,"amount":8620,"timestamp":1786454700041,"change":-0.57,"changeRate":-0.013052,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":40.87,"preClose":42.05,"latestTime":"19:42 EDT","volume":2746,"amount":115233.3,"timestamp":1786491764637,"change":-1.18,"changeRate":-0.028062,"amplitude":0.028062},"volumeRatio":1.52949,"impliedVol":0.7451,"impliedVolPercentile":0.6574},"requestUrl":"/m/hq/s/ETON","defaultTab":"news","newsList":[{"id":"1168553362","title":"财报前瞻｜Eton Pharmaceuticals, Inc.本季度营收预计增62.24%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1168553362","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168553362?lang=zh_cn&edition=full","pubTime":"2026-08-06 10:36","pubTimestamp":1785983801,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc.将于2026年08月13日发布最新季度财报，市场关注营收高增与盈利修复节奏。市场一致预期显示，本季度公司营收预计为2,711.30万美元，同比增62.24%；EBIT预计为408.00万美元，同比增687.40%；调整后每股收益预计为0.12美元，同比增413.61%。上季度公司实现营收2,426.60万美元，同比增长40.41%；毛利率62.17%；归属于母公司股东的净利润为155.40万美元，净利率6.40%；调整后每股收益为0.05美元，同比下降28.57%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Eton Pharmaceuticals, Inc.本季度营收预计增62.24%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157822179","title":"Eton Pharmaceuticals通过收购晚期候选药物Asn-001美国权益，拓展婴儿血管瘤产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=1157822179","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157822179?lang=zh_cn&edition=full","pubTime":"2026-08-05 18:51","pubTimestamp":1785927091,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals（简称Eton Pharmaceuticals, Inc.）宣布，已通过收购晚期候选产品Asn-001的美国权益，进一步拓展其婴儿血管瘤（Infantile Hemangioma）业务板块。此举标志着公司在该治疗领域的战略布局迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191197084","title":"Eton Pharmaceuticals 提交补充申请，拟扩大 Khindivi® (氢化可的松) 口服溶液适应症范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1191197084","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191197084?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:59","pubTimestamp":1785322760,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc.（简称Eton Pharmaceuticals）近日宣布，已正式提交一份补充申请，旨在拓展旗下产品 Khindivi®（氢化可的松）口服溶液的适应症。这一动作标志着该公司在扩大该药物市场应用方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169454238","title":"Eton Pharmaceuticals Inc 获Impavido美国独家商业化权利 自2026年9月26日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1169454238","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169454238?lang=zh_cn&edition=full","pubTime":"2026-05-20 04:31","pubTimestamp":1779222693,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Inc 宣布获得Impavido在美国市场的独家商业化权利，该授权将于2026年9月26日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107071325","title":"伊顿制药通过获取英帕维多®美国商业化权益协议，拓展罕见病产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1107071325","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107071325?lang=zh_cn&edition=full","pubTime":"2026-05-20 04:30","pubTimestamp":1779222611,"startTime":"0","endTime":"0","summary":"伊顿制药公司宣布，已签署一项协议，获得英帕维多®（米替福新）在美国的商业化权利。此举标志着该公司在其罕见病治疗领域的产品组合得到了进一步扩展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131923378","title":"Eton Pharmaceuticals携Eton Cares计划及独家专业药房分销渠道重新推出Hemangeol®（普萘洛尔）口服溶液","url":"https://stock-news.laohu8.com/highlight/detail?id=1131923378","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131923378?lang=zh_cn&edition=full","pubTime":"2026-05-01 18:51","pubTimestamp":1777632680,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc. (ETON) 宣布，其旗下产品Hemangeol®（普萘洛尔）口服溶液已正式重新上市。此次重启伴随着公司推出的\"Eton Cares\"患者支持计划，旨在为用药患者提供全方位的协助。同时，该产品将通过独家专业药房渠道进行分销，以确保药品的可及性与专业服务支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158617122","title":"Eton Pharmaceuticals公布首席财务官继任计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1158617122","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158617122?lang=zh_cn&edition=full","pubTime":"2026-04-16 18:52","pubTimestamp":1776336736,"startTime":"0","endTime":"0","summary":"伊利诺伊州迪尔帕克，2026年4月16日——专注于罕见病治疗药物研发与商业化的创新制药公司Eton Pharmaceuticals, Inc.今日宣布，任命朱迪丝·M·马修斯为执行副总裁，主管会计与财务。马修斯女士将于2026年6月1日正式出任公司首席财务官。公司现任首席财务官詹姆斯·格鲁伯将按既定继任计划卸任。Eton Pharmaceuticals首席执行官肖恩·布林杰尔森表示：\"我们热烈欢迎朱迪加入Eton。在加入Eton之前，她于2015年至2026年期间担任Iterum Therapeutics plc的首席财务官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4555","TM","BK4585","BK4007","03160","BK4022","R","BK4604","BK4099","BK4588","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188903638","title":"Eton Pharmaceuticals收购Hemangeol®口服溶液美国商业化权益，拓展罕见病产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1188903638","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188903638?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:29","pubTimestamp":1772454574,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc.宣布通过收购Hemangeol®（盐酸普萘洛尔）口服溶液在美国的商业化权利，进一步扩大其在罕见病领域的业务布局。此次交易将强化该公司在专科治疗市场的产品管线，为罕见病患者提供更多治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124358034","title":"Eton Pharmaceuticals 与Pierre Fabre Medicament Sas达成许可协议，获得Hemangeol口服溶液美国市场权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1124358034","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124358034?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:17","pubTimestamp":1772453828,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc. 已签署一项授权协议，成功从Pierre Fabre Medicament Sas公司收购了Hemangeol口服溶液在美国的独家销售权。此次交易将进一步加强Eton在美国医药市场的产品布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112408922","title":"Eton制药公司：将在交易完成时购入约150万美元库存，并预计于2026年5月再购入约70万美元库存","url":"https://stock-news.laohu8.com/highlight/detail?id=1112408922","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112408922?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:15","pubTimestamp":1772453733,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals, Inc. 宣布，除核心资产收购外，公司还计划在交易交割时购入价值约150万美元的库存产品。此外，根据安排，预计在2026年5月将再购入约70万美元的库存。这一举措旨在进一步充实公司的产品储备，支持其长期业务拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518327430","title":"Eton Pharmaceuticals, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518327430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518327430?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:01","pubTimestamp":1741615275,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时01分，Eton Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.07%。截至发稿，该股报13.85美元/股，成交量1.4945万股，换手率0.06%，振幅3.01%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为1.48%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 、Scilex Holding Company涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为339.21%、13.90%、10.51%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Sonoma Pharmaceuticals, Inc.、苏轩堂，振幅分别为35.91%、31.15%、29.45%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022011696403dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022011696403dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517196976","title":"Eton Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517196976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517196976?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:05","pubTimestamp":1741284316,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时05分，Eton Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.27%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为1.64%。其相关个股中，博美集团、Cyclo Therapeutics, Inc.、惠普森医药涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、德纳维制药较为活跃，换手率分别为18.20%、9.47%、8.47%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Medicus Pharma Ltd.，振幅分别为33.03%、26.67%、21.58%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307020516989eda17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307020516989eda17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516037670","title":"Eton Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.24%报16.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516037670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516037670?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:59","pubTimestamp":1740758347,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时59分，Eton Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.24%。截至发稿，该股报16.26美元/股，成交量5.4303万股，换手率0.21%，振幅7.77%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.26%。其相关个股中，Organogenesis Holdings Inc.、百利高、Sunshine Biopharma Inc C/Wts 涨幅较大，Organogenesis Holdings Inc.、苏轩堂、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为30.34%、11.69%、7.96%，振幅较大的相关个股有Organogenesis Holdings Inc.、Sunshine Biopharma Inc C/Wts 、苏轩堂，振幅分别为57.65%、44.90%、18.00%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823590796342d2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823590796342d2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514382766","title":"Eton Pharmaceuticals, Inc.盘中异动 股价大涨5.09%报15.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514382766?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:20","pubTimestamp":1740673223,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时20分，Eton Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.09%。截至发稿，该股报15.83美元/股，成交量11.6795万股，换手率0.45%，振幅6.24%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为1.18%。其相关个股中，Ironwood医药、Medicus Pharma Ltd.、Bioage Labs, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、大自然药业较为活跃，换手率分别为26.80%、14.39%、8.02%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Scilex Holding Company、Petros Pharmaceuticals, Inc.，振幅分别为34.88%、24.00%、23.11%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800202398952661&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800202398952661&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514616848","title":"Eton Pharmaceuticals, Inc.盘中异动 股价大涨5.95%报14.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514616848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514616848?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:16","pubTimestamp":1740597364,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时16分，Eton Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.95%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.61%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Lantheus Holdings, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、Quantum Biopharma Ltd.较为活跃，换手率分别为36.33%、35.30%、19.06%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Quantum Biopharma Ltd.，振幅分别为67.44%、36.28%、26.52%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227031604963182bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227031604963182bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514413011","title":"Eton Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.21%报13.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514413011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514413011?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:41","pubTimestamp":1740501660,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时41分，Eton Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.21%。截至发稿，该股报13.52美元/股，成交量9.6363万股，换手率0.37%，振幅5.82%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为1.44%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Biofrontera Inc C/Wts 27/10/2026 、Talphera, Inc.涨幅较大，Redhill Biopharma Ltd、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为174.53%、172.91%、84.60%，振幅较大的相关个股有Redhill Biopharma Ltd、Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc C/Wts ，振幅分别为56.85%、49.75%、42.50%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600410096300e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600410096300e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512485698","title":"Eton Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.20%报16.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512485698?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:59","pubTimestamp":1739977151,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时59分，Eton Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.20%。截至发稿，该股报16.24美元/股，成交量1.634万股，换手率0.06%，振幅3.88%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.27%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Gelteq Limited、和黄医药涨幅较大，Petros Pharmaceuticals, Inc.、Painreform Ltd.、大自然药业较为活跃，换手率分别为28.24%、23.68%、7.62%，振幅较大的相关个股有Painreform Ltd.、Flora Growth Corp.、Cbdmd, Inc.，振幅分别为10.24%、9.30%、8.24%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192259119628d25f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192259119628d25f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511611819","title":"Eton Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.03%报15.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511611819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511611819?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:26","pubTimestamp":1739561196,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时26分，Eton Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.03%。截至发稿，该股报15.97美元/股，成交量11.3101万股，换手率0.43%，振幅5.17%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为1.52%。其相关个股中，Petros Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 、Medicus Pharma Ltd.涨幅较大，Petros Pharmaceuticals, Inc.、Quantum Biopharma Ltd.、Cbdmd, Inc.较为活跃，换手率分别为896.66%、19.27%、18.22%，振幅较大的相关个股有Petros Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 、Cyclo Therapeutics Inc C/Wts 11/12/2025，振幅分别为158.95%、66.67%、49.79%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215032636abcf4458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215032636abcf4458&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509725922","title":"Eton Pharmaceuticals, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509725922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509725922?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:33","pubTimestamp":1738852414,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时33分，Eton Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.04%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.71%。其相关个股中，Cyclo Therapeutics Inc C/Wts 11/12/2025、Quantum Biopharma Ltd.、Sunshine Biopharma Inc C/Wts 涨幅较大，Quantum Biopharma Ltd.、大自然药业、坎伯兰药业较为活跃，换手率分别为227.93%、12.07%、3.50%，振幅较大的相关个股有Quantum Biopharma Ltd.、Cyclo Therapeutics Inc C/Wts 11/12/2025、极光大麻，振幅分别为14.22%、6.92%、6.70%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223334987c8f17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223334987c8f17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509641404","title":"Eton Pharmaceuticals, Inc.盘中异动 快速上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509641404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509641404?lang=zh_cn&edition=full","pubTime":"2025-02-05 01:06","pubTimestamp":1738688806,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日01时06分，Eton Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.13%。Eton Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.25%。其相关个股中，Quantum Biopharma Ltd.、坎伯兰药业、Journey Medical Corporation涨幅较大，Quantum Biopharma Ltd.、坎伯兰药业、大自然药业较为活跃，换手率分别为2411.81%、71.49%、15.65%，振幅较大的相关个股有Quantum Biopharma Ltd.、Scilex Holding Company C/Wts 10/11/2027 、坎伯兰药业，振幅分别为42.75%、34.95%、18.73%。Eton Pharmaceuticals, Inc.公司简介：Eton Pharmaceuticals Inc是一家总部位于美国的专业制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205010646987a62c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205010646987a62c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.etonpharma.com","stockEarnings":[{"period":"1week","weight":-0.0326},{"period":"1month","weight":0.1928},{"period":"3month","weight":0.4699},{"period":"6month","weight":1.7209},{"period":"1year","weight":1.5478},{"period":"ytd","weight":1.5825}],"compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.0239},{"period":"3month","weight":0.0472},{"period":"6month","weight":0.1172},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1336}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Eton Pharmaceuticals, Inc.于2017年4月27日根据特拉华州法律成立。该公司是一家创新制药公司，专注于开发、获取和商业化创新产品，以满足罕见病患者未得到满足的需求。该公司目前有四种商业罕见病产品，ALKINDI SPRINKLE用于治疗肾上腺皮质功能不全，谷氨酸用于治疗N-乙酰谷氨酸合酶缺乏引起的高氨血症；甜菜碱无水用于治疗同型半胱氨酸尿症；尼替西农用于治疗1型遗传性酪氨酸血症，另外还有三种候选产品处于后期开发阶段。该公司正在开发脱水酒精注射液，已获得治疗甲醇中毒的孤儿药资格，用于治疗肾上腺危象的ZENEO氢化可的松自动注射器和ET-400。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.049574},{"month":2,"riseRate":0.5,"avgChangeRate":0.007501},{"month":3,"riseRate":0.5,"avgChangeRate":0.000763},{"month":4,"riseRate":0.375,"avgChangeRate":0.041311},{"month":5,"riseRate":0.625,"avgChangeRate":0.018979},{"month":6,"riseRate":0.25,"avgChangeRate":-0.044284},{"month":7,"riseRate":0.5,"avgChangeRate":0.004018},{"month":8,"riseRate":0.625,"avgChangeRate":0.124608},{"month":9,"riseRate":0.571429,"avgChangeRate":0.07288},{"month":10,"riseRate":0.571429,"avgChangeRate":0.067693},{"month":11,"riseRate":0.571429,"avgChangeRate":0.051311},{"month":12,"riseRate":0.625,"avgChangeRate":0.051914}],"exchange":"NASDAQ","name":"Eton Pharmaceuticals, Inc.","nameEN":"Eton Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eton Pharmaceuticals, Inc.(ETON)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Eton Pharmaceuticals, Inc.(ETON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Eton Pharmaceuticals, Inc.,ETON,Eton Pharmaceuticals, Inc.股票,Eton Pharmaceuticals, Inc.股票老虎,Eton Pharmaceuticals, Inc.股票老虎国际,Eton Pharmaceuticals, Inc.行情,Eton Pharmaceuticals, Inc.股票行情,Eton Pharmaceuticals, Inc.股价,Eton Pharmaceuticals, Inc.股市,Eton Pharmaceuticals, Inc.股票价格,Eton Pharmaceuticals, Inc.股票交易,Eton Pharmaceuticals, Inc.股票购买,Eton Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eton Pharmaceuticals, Inc.(ETON)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Eton Pharmaceuticals, Inc.(ETON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}